Research context
An experimental small molecule, not a peptide, studied in preclinical metabolic research.
Metabolic research
An experimental small molecule, not a peptide, studied in preclinical metabolic research.
An experimental small molecule, not a peptide, studied in preclinical metabolic research.
Evidence map
Evidence levels describe study design. They do not by themselves establish safety or effectiveness.
Can SLU-PP-332 be a new drug to prevent COVID-19?
Abstract 9682: The Cardiac Protective Effects of Novel Synthetic Pan-Estrogen Related Receptor Agonists Slu-pp-332 and Slu-pp-915
Rödlistade arter i Sverige 2025
SLU-PP-332 AND RELATED ERRα AGONISTS: A FOCUSED MINIREVIEW OF METABOLIC REGULATION, AND THERAPEUTIC POTENTIAL
Sustainable systems for integrated fish and vegetable production: new perspectives on aquaponics
SLU Journal of Science and Technology
Developments in proximal crop sensing for precision agriculture
Can SLU-PP-332 be a new drug to prevent COVID-19?
In Vitro Metabolism and Analytical Characterization of SLU‐PP‐332 and SLU‐PP‐915: Novel Pan‐ERR Agonists With Doping Potential
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function
A Synthetic ERR Agonist Alleviates Metabolic Syndrome
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney
A Synthetic ERRα Agonist Induces an Acute Aerobic Exercise Response and Enhances Exercise Capacity
Unlocking the potential: SLU-PP-332 and the future of exercise Enhancement and Metabolic health
[Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications].
Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.
Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.
In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.
In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.
Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.
A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
In Vitro Metabolism and Analytical Characterization of SLU‐PP‐332 and SLU‐PP‐915: Novel Pan‐ERR Agonists With Doping Potential
Connected data hub
Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.
Bonanni R, Falvino A, Matticari A, Rinaldi AM, D'Arcangelo G, Cifelli P, Iundusi R, Gasbarra E, Tancredi V, Cariati I, Tarantino U · Frontiers in physiology
Okda HE, Zhao P, Hayes M, Duvall C, Quillin E, Fang H, Mohammed BM, Hegazy L, Burris TP, Elgendy B · International journal of biological macromolecules
Wang XX, Myakala K, Libby AE, Krawczyk E, Panov J, Jones BA, Bhasin K, Shults N, Qi Y, Krausz KW, Zerfas PM, Takahashi S, Daneshpajouhnejad P, Titievsky A, Taranenko E, Billon C, Chatterjee A, Elgendy B, Walker JK,...
Möller T, Krug O, Thevis M · Rapid communications in mass spectrometry : RCM
Billon C, Schoepke E, Avdagic A, Chatterjee A, Butler AA, Elgendy B, Walker JK, Burris TP · The Journal of pharmacology and experimental therapeutics
Xu W, Billon C, Li H, Wilderman A, Qi L, Graves A, Rideb JRDC, Zhao Y, Hayes M, Yu K, Losby M, Hampton CS, Adeyemi CM, Hong SJ, Nasiotis E, Fu C, Oh TG, Fan W, Downes M,...
Billon C, Sitaula S, Banerjee S, Welch R, Elgendy B, Hegazy L, Oh TG, Kazantzis M, Chatterjee A, Chrivia J, Hayes ME, Xu W, Hamilton A, Huss JM, Zhang L, Walker JK, Downes M, Evans RM, Burris TP...
Bonanni R, Falvino A, Matticari A, Rinaldi AM, D'Arcangelo G, Cifelli P, Iundusi R, Gasbarra E, Tancredi V, Cariati I, Tarantino U
Okda HE, Zhao P, Hayes M, Duvall C, Quillin E, Fang H, Mohammed BM, Hegazy L, Burris TP, Elgendy B
Avliyakulov NK, Sobolevsky T, Ahrens E
de Souza-Lima J, Astrosa-Martin BD, Galaz-Rodríguez CA, Silva-Bernal JE, Orellana-Pizarro LI, Mena-Díaz CA
Billon C, Appourchaux K, Côté I, Burris TP
Möller T, Krug O, Thevis M
Xu W, Billon C, Li H, Wilderman A, Qi L, Graves A, Rideb JRDC, Zhao Y, Hayes M, Yu K, Losby M, Hampton CS, Adeyemi CM, Hong SJ, Nasiotis E, Fu C, Oh TG, Fan W, Downes M,...
Billon C, Schoepke E, Avdagic A, Chatterjee A, Butler AA, Elgendy B, Walker JK, Burris TP
Tristan Möller, Oliver Krug, Mario Thevis · Rapid Communications in Mass Spectrometry · 1 citations
Bhupendra M. Mahale, Akshata M. Girase, Maheshwari M. Mahale · Research Journal of Science and Technology · 0 citations
Bogdan-Alexandru HAGIU · Medical Hypotheses · 1 citations
Weiyi Xu, Cyrielle Billon, Hui Li, Andrea Scarpa Wilderman, Lei Qi, Andrea Graves et al. · Circulation · 67 citations
Cyrielle Billon, Emmalie Schoepke, Amer Avdagic, Arindam Chatterjee, Andrew A. Butler, Bahaa Elgendy et al. · Journal of Pharmacology and Experimental Therapeutics · 30 citations
Xiaoxin X. Wang, Komuraiah Myakala, Andrew E. Libby, Ewa Krawczyk, Julia Panov, Bryce A. Jones et al. · American Journal Of Pathology · 46 citations
Cyrielle Billon, Sadichha Sitaula, Subhashis Banerjee, Ryan D. Welch, Bahaa Elgendy, Lamees Hegazy et al. · ACS Chemical Biology · 43 citations
ABSTRACT Rationale Estrogen‐related receptor (ERR) agonists such as the drug candidates SLU‐PP‐332 and SLU‐PP‐915 are currently being investigated as exercise mimetics, given their ability to trigger human physiological processes similar to those initiated by actual physical activity. This...
Rödlistade arter i Sverige 2025 redovisar risken för att enskilda arter av djur, växter, svampar och alger ska försvinna från Sverige. Den är framtagen enligt IUCN:s rödlistningskriterier. I rödlistan bedöms risken att enskilda arter av djur, växter, svampar...
This chapter presents an overview of proximal sensing techniques used in practical precision agriculture, with the overall aim of contributing to more sustainable crop production. To provide perspective on the usefulness of crop sensors, the chapter starts with...
The global burden of metabolic disorders, including obesity and type 2 diabetes, necessitates innovative therapeutic strategies. SLU-PP-332, a synthetic agonist of estrogen-related receptor α (ERRα), has emerged as a promising exercise mimetic, demonstrating preclinical efficacy in enhancing mitochondrial...
B.-A. Hagiu · Elsevier BV
Introduction: Estrogen receptor-related orphan receptors ERRα and ERRγ are essential regulators for cardiac metabolism. Mice lacking ERRα and ERRγ develops lethal cardiomyopathy and heart failure. Therefore, activation of ERR is a potential therapeutic intervention for HF treatment. However,...
B. W. Alsanius, S. Khalil, A. Tadesse, A. K. Rosberg, K. J. Bergstrand, R. Hartmann, L. Mogren, M. Alam, M. Grudén, T. Naznin, A. Getahun · Burleigh Dodds Science Publishing
· Sule Lamido University Kafin Hausa
Cyrielle Billon, Sadichha Sitaula, Subhashis Banerjee, Ryan D. Welch, Bahaa Elgendy, Lamees Hegazy et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2 citations
Live discovery
Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.
Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.